Clinical Research That You Can Depend On


At CliniExperts Research Services, we are focused on conducting high-quality clinical trials in line with ethical and regulatory compliance with the aim to become your go-to Clinical Research Organization (CRO).

About Group

Since 2018, we have been fully dedicated to satisfying this demand by managing complete clinical trials. To this day, we continue to make a mark by providing safe and reliable clinical trial solutions with PAN India coverage.

Quality

High-quality
clinical trials

Expert guidance at each step for your product launch along with hassle free regulatory approvals

Efficiency

Efficient
services

Our customized services are designed to address your specific needs and deliver a smooth development pathway for your product launch

Lab

Go-to Clinical Research Organization (CRO)

Focusing on high-quality clinical trial management services, we aim to be your one stop CRO

Therapeutic expertise

Leadership team that combines expertise with passion

No. of sites

80+

Investigator Database

750+

No. of successful studies

120+

Our Team

Leadership team that combines expertise with passion

AshwaniKumar

Dr. Ashwini Kumar

Chief Executive Officer

Dr. Ashwini Kumar is an accomplished clinical researcher and regulatory affairs expert with over 17 years of experience in the pharmaceutical industry. He holds an M.D. in Biophysics from the prestigious All India Institute of Medical Sciences (AIIMS) and is committed to ensuring the highest standards of ethical practices and optimal outcomes .

As the Founder and CEO of CliniExperts Services since 2009, he has led the company to become India’s go-to healthcare regulatory brand. Dr. Kumar founded Cliniexperts Research driven by his passion for clinical research. It is now renowned for delivering world-class clinical research and trials.

Prior to founding CliniExperts, Dr. Kumar served as a Medical Monitor overseeing regulatory affairs, training operations, and quality assurance.

Dr. Kumar has been recognized as a promising entrepreneur by The Economics Times and The Business APAC Healthcare Elites of 2019.

Rashmi

Rashmi Verma

Chief Operating Officer

Rashmi helms the tactical, operational, administration, people policy, accounts and payroll, and growth and expansion functions of CliniExperts. She also acts as the company-industry interface. Being an IT post-graduate, Rashmi heads CliniEpxerts’ digital transformation drive, and aspires to achieve the digital-first status shortly.

Prasad Babu M

Prasad Babu M

Head - Clinical Operations

With 17 years of experience in Clinical Trial Management, Prasad Babu is a skilled leader adept at fostering collaboration and achieving collective goals. His strategic mindset is evident in optimizing processes across various therapeutic areas. Holding Masters degrees in Biotechnology and Pharma Business Management, he leads Clinical Operations with a commitment to quality, setting high standards, allocating resources effectively, and implementing corrective actions, showcasing his multifaceted skill set in the field.

Avatar 2

Dr. Veena RM

Head - Medical Affairs

Ms. Veena, MD in pharmacology, leads Deck as the VP Medical Affairs, specializing in Cardio-diabetics, Nephrology, Oncology, and Critical Care. With expertise in KOL engagement, she conducts advisory board meetings, resolves medical queries, and delivers scientific presentations. Veena excels in medico-marketing, healthcare advertising, and maintaining professional relationships with KOLs. Her fluency in English and comprehensive knowledge in Cardiovascular, Renal & Metabolic Disease make her an invaluable leader, ensuring Deck's success in the pharmaceutical industry.

Driving Clinical Excellence: Unveiling CliniExperts' Expertise

A seamless blend of scientific expertise, operational efficiency, and unparalleled client support

Expert Articles

Drug
Real-World Evidence in India: An Untapped Opportunity for Global Pharmaceutical Companies
Introduction The Pharmaceutical industry has long recognised that randomised controlled trials (RCTs), while the gold standard for establishing efficacy, cannot fully capture how Drugs perform across diverse patient populations in routine clinical practice. Real-world evidence (RWE) — data generated outside traditional randomised controlled trials, including electronic health records, claims databases, disease registries, and prospective observational
Biologicals |
Clinical Trials |
Diagnostic Kits |
Drug |
Medical Devices
Understanding Informed Consent in Clinical Research
Informed consent in clinical research is a cornerstone of ethical regulatory compliance. It ensures that participants voluntarily decide whether to take part in a study after receiving adequate information about its purpose, procedures, risks, benefits, and alternatives. It is an ongoing process that promotes transparency, protects participants’ rights, and supports autonomous decision-making. Introduction Informed consent
Drug
Subsequent New Drug (SND): Regulatory Pathway & Clinical Trial Requirements
A subsequent New Drug (SND) refers to an approved Drug that is modified and requires fresh regulatory approval before marketing. The process includes defined application cases, detailed evaluation, and sometimes clinical trial support. Regulatory authorities check safety, quality, and effectiveness at each step. Clinical trial guidelines ensure ethical conduct and reliable data generation, helping to
Drug
Investigational New Drug (IND) Application in India: Requirements & Proces
The Investigational New Drug application process in India is a structured regulatory framework that enables safe initiation of human clinical trials. It requires submission of preclinical and supporting scientific data for a detailed review by authorities. The evaluation focuses on safety, quality, and ethical compliance under the Second Schedule of New Drugs and Clinical Trial

*All the above fields are mandatory
contact us 2
Enquire now